novartis - dofaq.co
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters - 29 Apr 2024
Morphosys says takeover by Novartis on course after report of drug safety concern ...
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT - 28 Apr 2024
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition ...
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace - 29 Apr 2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT ...
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech - 30 Apr 2024
Novartis pays PeptiDream $180M as radiopharma big bang continues ...
Novartis reports 25% increase in net income in Q1 2024
Pharmaceutical Technology - 24 Apr 2024
Novartis reports 25% increase in net income in Q1 2024 ...
Research and development
Novartis - 08 Feb 2024
Research and development ...
Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs
FiercePharma - 23 Apr 2024
Novartis dials up 2024 sales outlook, preps for key expansions of 3 cancer drugs ...
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes
IAM - 24 Apr 2024
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes ...
Morphosys says Novartis takeover progressing as planned for H1 2024
XM - 29 Apr 2024
Morphosys says Novartis takeover progressing as planned for H1 2024 ...
Deciphex partners with Novartis for AI drug research
SiliconRepublic.com - 28 Apr 2024
Deciphex partners with Novartis for AI drug research ...
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ...
Medicines for Malaria Venture - 24 Apr 2024
Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies ... ...
Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO
FiercePharma - 23 Apr 2024
Novartis 'actively' reviewing relationships with Chinese contractors amid US biosecurity crackdown: CFO ...
Novartis in Society Integrated Report
Novartis - 31 Jan 2024
Novartis in Society Integrated Report ...
Novartis raises guidance after beating Q1 expectations
Reuters - 23 Apr 2024
Novartis raises guidance after beating Q1 expectations ...
Novartis bags paediatric FDA label expansion for Lutathera
Pharmaceutical Technology - 24 Apr 2024
Novartis bags paediatric FDA label expansion for Lutathera ...
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
FiercePharma - 26 Apr 2024
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia ...
Novartis begins tender offer for cancer-focused MorphoSys
Reuters - 11 Apr 2024
Novartis begins tender offer for cancer-focused MorphoSys ...
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair
FiercePharma - 23 Apr 2024
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair ...
Novartis to cut 680 jobs in product development
Reuters - 09 Apr 2024
Novartis to cut 680 jobs in product development ...